A Randomized, Double Blind, Placebo Controlled, Cross-over, and Fixed Dose Study to Evaluate the Safety and Efficacy of DLBS1033 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Lumbricus rubellus (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 22 Aug 2012 Actual end date changed from November 2011 to Jul 2011 as reported by ClinicalTrials.gov.
- 10 Feb 2012 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
- 10 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.